Position in XLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$116,058
-$596,404 QoQ
Shares Held
13,800
-98.8% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ghisallo Capital Management LLC holds $16,940,228 across 16 Biotechnology names. XLO ranks #16 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
250,000 | $4,470,000 | |
| 2 | ALMS |
Alumis Inc.
|
100,000 | $2,203,000 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
100,000 | $1,920,000 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
5,000 | $1,610,950 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
25,000 | $1,452,750 | |
| 6 | CADL |
Candel Therapeutics, Inc.
|
200,000 | $980,000 | |
| 7 | DRUG |
Bright Minds Biosciences Inc.
|
11,000 | $802,670 | |
| 8 | EIKN |
Eikon Therapeutics, Inc.
|
70,000 | $740,600 |
All Filings in XLO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $116,058 | 13,800 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $712,462 | 1,113,222 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $906,439 | 1,333,000 | Shares | Sole | 2025-08-14 | |
| 2021-12-31 | $479,999 | 30,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||